Sara Bay Financial Oragenics Inc Transaction History

Sara Bay Financial

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	SELL	$0.11 - $15.59 $81,051 - $11.5 Million	-736,836 Reduced 36.69%	1,271,281 $134 Million
Q4 2021 Jan 14, 2022	BUY	$0.43 - $0.69 $430,000 - $690,000	1,000,000 Added 99.19%	2,008,117 $896 Million
Q4 2020 Jan 15, 2021	SELL	$0.39 - $0.6 $120,900 - $186,000	-310,000 Reduced 23.52%	1,008,117 $453 Million
Q3 2020 Oct 07, 2020	SELL	$0.56 - $1.49 $1,680 - $4,470	-3,000 Reduced 0.23%	1,318,117 $758 Million
Q2 2020 Jul 21, 2020	BUY	$0.39 - $0.83 $515,235 - $1.1 Million	1,321,117 New	1,321,117 $1.07 Billion

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $36.1M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Sara Bay Financial, based on Form 13F filings with the SEC.

Stay updated on Sara Bay Financial with notifications on news.